Literature DB >> 6784683

Relationship of gold and penicillamine therapy to diffuse interstitial lung disease.

D L Scott, G V Bradby, T J Aitman, G C Zaphiropoulos, C F Hawkins.   

Abstract

Seven cases of diffuse interstitial lung disease (DILD) are reported with an unequivocal temporal relationship between the development of the lung disease and treatment with gold (6 cases) and penicillamine (1 case). They were characterised clinically by the sudden onset of dyspnoea and crepitations and radiologically by diffuse bilateral pulmonary shadowing. Most showed evidence of hypersensitivity such as eosinophilia, a raised serum IgE level in response to gold, proteinuria, thrombocytopenia, or an immediate postinjection reaction. DILD is a serious complication of treatment with gold and penicillamine that is commoner than generally realised.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6784683      PMCID: PMC1000695          DOI: 10.1136/ard.40.2.136

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

1.  Letter: Goodpasture syndrome and D-penicillamine.

Authors:  T Gibson; H C Burry; C Ogg
Journal:  Ann Intern Med       Date:  1976-01       Impact factor: 25.391

2.  Diffuse alveolitis as complication of penicillamine treatment for rheumatoid arthritis.

Authors:  C J Eastmond
Journal:  Br Med J       Date:  1976-06-19

3.  Significance of eosinophilia during gold therapy.

Authors:  P Davis; G R Hughes
Journal:  Arthritis Rheum       Date:  1974 Nov-Dec

4.  Azathioprin nd acute restrictive lung disese.

Authors:  G Rubin; P Baume; R Vandenberg
Journal:  Aust N Z J Med       Date:  1972-08

5.  Pulmonary lesions and rheumatoid arthritis.

Authors:  W C Walker; V Wright
Journal:  Medicine (Baltimore)       Date:  1968-11       Impact factor: 1.889

6.  D-penicillamine induced Goodpasture's syndrome in Wilson's disease.

Authors:  I Sternlieb; B Bennett; I H Scheinberg
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

7.  Pulmonary fibrosis associated with hypersensitivity to gold salts.

Authors:  D M Geddes; J Brostoff
Journal:  Br Med J       Date:  1976-06-12

8.  Postinjection nonvasomotor reactions during chrysotherapy. Constitutional and rheumatic symptoms following injections of gold salts.

Authors:  J T Halla; J G Hardin; J E Linn
Journal:  Arthritis Rheum       Date:  1977 Jul-Aug

9.  Diffuse pulmonary injury associated with gold treatment.

Authors:  R H Winterbauer; K R Wilske; R F Wheelis
Journal:  N Engl J Med       Date:  1976-04-22       Impact factor: 91.245

10.  Pulmonary fibrosis following therapy with Melphalan for multiple myeloma.

Authors:  B W Codling; T M Chakera
Journal:  J Clin Pathol       Date:  1972-08       Impact factor: 3.411

View more
  12 in total

Review 1.  Adverse reactions with oral and parenteral gold preparations.

Authors:  E C Tozman; N L Gottlieb
Journal:  Med Toxicol       Date:  1987 May-Jun

2.  Gold-induced lung disease.

Authors:  J Heyd; A Simmeran
Journal:  Postgrad Med J       Date:  1983-06       Impact factor: 2.401

3.  Fatal bronchiolitis obliterans associated with chrysotherapy.

Authors:  L Holness; J Tenenbaum; N B Cooter; R F Grossman
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

4.  Pulmonary damage with gold or penicillamine.

Authors:  A Bamji; N Cooke
Journal:  Ann Rheum Dis       Date:  1981-10       Impact factor: 19.103

5.  Cholestasis and pneumonitis induced by gold therapy.

Authors:  J M Farre; T Perez; P Hautefeuille; F Tonnel; J F Colombel; B Duquesnoy; B Delcambre
Journal:  Clin Rheumatol       Date:  1989-12       Impact factor: 2.980

Review 6.  Drug-induced respiratory disorders: incidence, prevention and management.

Authors:  L Ben-Noun
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

7.  A comparative trial of timegadine and D-penicillamine in rheumatoid arthritis.

Authors:  J M Mbuyi-Muamba; J Dequeker
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

8.  Primary biliary cirrhosis with fibrosing alveolitis.

Authors:  M Osaka; T Aramaki; H Okumura; O Kawanami
Journal:  Gastroenterol Jpn       Date:  1988-08

9.  Rheumatoid arthritis with extensive lung lesions.

Authors:  C Fellbaum; W Domej; H Popper
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

10.  Connective Tissue Disease-associated Interstitial Lung Disease: A review.

Authors:  Markus Gutsche; Glenn D Rosen; Jeffrey J Swigris
Journal:  Curr Respir Care Rep       Date:  2012-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.